Promoter methylation of the Wnt/β‐catenin signaling antagonist <i>Dkk‐3</i> is associated with poor survival in gastric cancer

Abstract

Epigenetic silencing of the Dkk-3 gene by promoter methylation was a common event in gastric cancer and was associated with a poor outcome in such patients.